Overview Financials News + Filings Key Docs Charts Ownership Insiders |
WebMD Health Corp. (WBMD)
|
Add to portfolio |
|
|
Price: |
$66.48
| | Metrics |
OS: |
37.8
|
M
| |
8
|
% ROE
|
Market cap: |
$2.51
|
B
| |
26
|
% ROIC
|
Net cash:
|
$663
|
M
| |
$17.52
|
per share
|
EV:
|
$1.85
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$173
|
M
| |
10.7
|
x EV/EBITDA
|
EBIT
|
$143
|
M
| |
13.0
|
x EV/EBIT
|
EPS |
$1.64
| |
40.6
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
Revenues | 705.0 | 636.4 | 580.4 | 515.3 | 469.9 | 558.8 | 534.5 | 438.5 |
Revenue growth | 10.8% | 9.6% | 12.6% | 9.7% | -15.9% | 4.5% | 21.9% | 17.4% |
Cost of goods sold | 266.7 | 247.3 | 224.1 | 209.7 | 216.4 | 201.7 | 187.8 | 165.8 |
Gross profit | 438.4 | 389.1 | 356.4 | 305.6 | 253.5 | 357.1 | 346.7 | 272.8 |
Gross margin | 62.2% | 61.1% | 61.4% | 59.3% | 54.0% | 63.9% | 64.9% | 62.2% |
Sales and marketing | 146.0 | 138.0 | 136.2 | 128.0 | 127.7 | 124.3 | 120.9 | 112.1 |
General and administrative | 91.1 | 91.6 | 94.1 | 93.2 | 97.6 | 91.3 | 85.5 | 89.6 |
EBITA | 143.2 | 101.0 | 74.3 | 34.4 | -16.2 | 110.5 | 91.9 | 17.5 |
EBITA margin | 20.3% | 15.9% | 12.8% | 6.7% | -3.5% | 19.8% | 17.2% | 4.0% |
Amortization of intangibles | 3.1 | 3.3 | 2.8 | 2.3 | 3.9 | 2.6 | 3.4 | 6.3 |
EBIT | 140.0 | 97.7 | 71.5 | 32.1 | -20.1 | 107.9 | 88.5 | 11.2 |
EBIT margin | 19.9% | 15.4% | 12.3% | 6.2% | -4.3% | 19.3% | 16.5% | 2.5% |
Pre-tax income | 146.8 | 99.9 | 71.6 | 28.8 | -25.2 | 110.4 | 72.3 | 26.2 |
Income taxes | 55.5 | 35.8 | 30.7 | 13.6 | -2.1 | 46.2 | 20.0 | -45.5 |
Tax rate | 37.8% | 35.9% | 42.9% | 47.4% | 8.5% | 41.8% | 27.7% | |
Earnings from continuing ops | 91.3 | 64.0 | 39.8 | 15.1 | -25.8 | 53.8 | 50.5 | 71.7 |
Earnings from discontinued ops | | | 1.1 | | 2.7 | 10.4 | 1.8 | 49.4 |
Net income | 91.3 | 64.0 | 40.9 | 15.1 | -23.1 | 64.2 | 52.3 | 121.0 |
Net margin | 13.0% | 10.1% | 7.1% | 2.9% | -4.9% | 11.5% | 9.8% | 27.6% |
|
Diluted EPS | $1.69 | $1.22 | $0.87 | $0.31 | ($0.51) | $0.91 | $0.81 | $1.24 |
Shares outstanding (diluted) | 54.2 | 52.7 | 45.6 | 48.4 | 50.9 | 59.1 | 62.2 | 57.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|